Sandip P. Patel, MD

home / authors / sandip-p-patel-md

Articles

A panel of 4 experts on lung cancer

August 19th 2024

Key Takeaways on Enhancing Outcomes for mNSCLC Without Targetable Driver Mutations

Mark Socinski, MD John Heymach, MD, PhD Wade Iams, MD Sandip P. Patel, MD

The panel provides insights on enhancing outcomes for patients with metastatic non-small cell lung cancer without targetable driver mutations.

A panel of 4 experts on lung cancer

August 12th 2024

Overcoming Immunotherapy Resistance: Identifying Non-Responders and Novel Approaches

Mark Socinski, MD John Heymach, MD, PhD Wade Iams, MD Sandip P. Patel, MD

The panel shares clinical practices for overcoming immunotherapy resistance in patients with non-small cell lung cancer.

A panel of 4 experts on lung cancer

August 12th 2024

Clinical Factors Impacting Immunotherapy Response and Optimizing Patient Selection

Mark Socinski, MD John Heymach, MD, PhD Wade Iams, MD Sandip P. Patel, MD

A panel of experts on non-small cell lung cancer outline factors that impact how well patients respond to immunotherapy.

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com

Published: November 15th 2024 | Updated: November 19th 2024

FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Published: November 1st 2024 | Updated: November 21st 2024

Table Multiple Myeloma Trials November 2024

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions